Follow the 휴비츠 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 휴비츠 has published 16 reports. Market capitalisation: €67.6bn. The latest transaction was reported on 9 March 2026 (Other). Among the most active insiders: 김현수. Every trade is free.
16
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
1 ops.
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,185 of 29,064 companies
33.5
score / 100
Value
31
Quality
36
FCF yld7.5%
Earn yld-7.4%
EV/EBITDA54.4x
ROE-3.2%
Gross mgn46%
Net mgn-4.2%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
휴비츠 es una empresa de atención médica y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para la salud y el bienestar del consumidor.